Canadian Respiratory Journal / 2018 / Article / Tab 3

Research Article

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients

Table 3

Comparison of echocardiographic data between patients with and without PoPH.

VariablePoPHNon-PoPH

EF (%)69.3 ± 6.667.0 ± 7.40.263
CO (L/min)6.4 ± 2.15.8 ± 1.80.214
PAD (mm)27.2 ± 5.522.8 ± 3.2<0.001
AORD (mm)31.4 ± 3.631.2 ± 3.30.771
LAD (mm)39.0 ± 3.838.3 ± 5.80.503
IVST (mm)8.0 ± 1.28.3 ± 1.30.404
LVDD (mm)51.6 ± 8.649.5 ± 5.70.198
LVSD (mm)31.9 ± 6.730.9 ± 4.20.585
LVPWT (mm)7.9 ± 0.78.2 ± 1.20.305
DDF, (%)0.794
 Yes5 (35.7)82 (39.2)
 No9 (64.3)127 (60.8)

EF, ejection fraction; CO, cardiac output; PAD, pulmonary artery diameter; AORD, aortic root diameter; LAD, left atrial diameter; IVST, interventricular septal thickness; LVDD, left ventricular end-diastolic diameter; LVSD, left ventricular end-systolic diameter; LVPWT, left ventricular posterior wall thickness; DDF, diastolic dysfunction.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.